Sodium channel protein type 2 subunit alpha
Also known as: HBA, NAC2, SCN2A, SCN2A1, SCN2A2
Function
Mediates the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a sodium-selective channel through which Na(+) ions may pass in accordance with their electrochemical gradient. Implicated in the regulation of hippocampal replay occurring within sharp wave ripples (SPW-R) important for memory (By similarity).
Classification
- Family (Pfam)
- PF00520 Ion_trans, PF24609 IQ_SCN5A_C, PF06512 Na_trans_assoc, PF11933 Na_trans_cytopl
- InterPro
- Ion_trans_dom, IQ_motif_EF-hand-BS, IQ_SCN5A_C, Na_channel_asu, Na_chnl_inactivation_gate, Na_trans_assoc_dom, Na_trans_cytopl, VGCC_Ca_Na, Volt_channel_dom_sf
- Functional cluster
- DEAD-Box RNA Helicases & Biogenesis Factors
Experimental structures · PDB · 5
A predicted model is available from AlphaFold.
Gene Ontology · 17
- GO:0030424 axon
- GO:0016020 membrane
- GO:0033268 node of Ranvier
- GO:0005886 plasma membrane
- GO:0001518 voltage-gated sodium channel complex
- GO:0005516 calmodulin binding
- GO:0005248 voltage-gated sodium channel activity
- GO:0086002 cardiac muscle cell action potential involved in contraction
- GO:0071456 cellular response to hypoxia
- GO:0008627 intrinsic apoptotic signaling pathway in response to osmotic stress
- GO:0007613 memory
- GO:0042552 myelination
- GO:0007399 nervous system development
- GO:0051402 neuron apoptotic process
- GO:0019228 neuronal action potential
- GO:0035725 sodium ion transmembrane transport
- GO:0006814 sodium ion transport
Disease associations
- seizures, benign familial infantile, 3 MONDO:0011904
- developmental and epileptic encephalopathy, 11 MONDO:0013388
- episodic ataxia, type 9 MONDO:0030064
Drugs targeting this protein · 56
- OXCARBAZEPINE blocker
- CARBAMAZEPINE blocker
- ETHOTOIN blocker
- PRILOCAINE blocker
- MORICIZINE HYDROCHLORIDE blocker
- INDECAINIDE HYDROCHLORIDE blocker
- ORPHENADRINE CITRATE blocker
- LIDOCAINE HYDROCHLORIDE blocker
- QUINIDINE GLUCONATE blocker
- MEPIVACAINE HYDROCHLORIDE blocker
- PROPARACAINE HYDROCHLORIDE blocker
- DYCLONINE HYDROCHLORIDE blocker
- PRILOCAINE HYDROCHLORIDE blocker
- ETIDOCAINE HYDROCHLORIDE blocker
- MEXILETINE HYDROCHLORIDE blocker
- BENOXINATE HYDROCHLORIDE blocker
- HEXYLCAINE HYDROCHLORIDE blocker
- TOCAINIDE HYDROCHLORIDE blocker
- ARTICAINE HYDROCHLORIDE blocker
- PROCAINE HYDROCHLORIDE blocker
- DISOPYRAMIDE PHOSPHATE blocker
- PHENAZOPYRIDINE HYDROCHLORIDE blocker
- ORPHENADRINE HYDROCHLORIDE blocker
- PROPAFENONE HYDROCHLORIDE blocker
- DRONEDARONE HYDROCHLORIDE blocker
- RUFINAMIDE blocker
- TETRACAINE HYDROCHLORIDE blocker
- PHENYTOIN blocker
- PHENYTOIN SODIUM blocker
- PROPOXYCAINE HYDROCHLORIDE blocker
- ROPIVACAINE HYDROCHLORIDE blocker
- ENCAINIDE HYDROCHLORIDE blocker
- NERISPIRDINE blocker
- RALFINAMIDE blocker
- TOPIRAMATE blocker
- IRAMPANEL blocker
- ELPETRIGINE blocker
- ESLICARBAZEPINE blocker
- DICHLOROBENZYL ALCOHOL blocker
- EVENAMIDE blocker
- QUINIDINE SULFATE blocker
- CENOBAMATE inhibitor
- COCAINE HYDROCHLORIDE blocker
- LACOSAMIDE blocker
- PROCAINAMIDE HYDROCHLORIDE blocker
- TETRACAINE blocker
- LAMOTRIGINE blocker
- RILUZOLE blocker
- ZONISAMIDE blocker
- LIDOCAINE blocker
- PRIMIDONE blocker
- MEPHENYTOIN blocker
- ESLICARBAZEPINE ACETATE blocker
- PHENACEMIDE blocker
- FOSPHENYTOIN SODIUM blocker
- CHLOROPROCAINE HYDROCHLORIDE blocker
Neighborhood · nearest proteins
Related proteins · sequence + function similarity
- Sodium channel protein type 2 subunit alpha 1.00
- Sodium channel protein type 2 subunit alpha 1.00
- Sodium channel protein type 3 subunit alpha 0.99
- Sodium channel protein type 3 subunit alpha 0.99
- Sodium channel protein type 3 subunit alpha 0.99
- Sodium channel protein type 9 subunit alpha 0.98
- Sodium channel protein type 9 subunit alpha 0.98
- Sodium channel protein type 8 subunit alpha 0.98
- Sodium channel protein type 1 subunit alpha 0.98
- Sodium channel protein type 8 subunit alpha 0.98
- Sodium channel protein type 8 subunit alpha 0.98
- Sodium channel protein type 9 subunit alpha 0.98
Co-cited proteins · studied together in the literature
- Sodium channel protein type 1 subunit alpha 16 shared papers
- Sodium channel protein type 3 subunit alpha 3 shared papers
- Glutamate receptor 3 1 shared papers
- Methyl-CpG-binding protein 2 5 shared papers
- Potassium voltage-gated channel subfamily KQT member 2 7 shared papers
- Cyclin-dependent kinase-like 5 5 shared papers
- Potassium voltage-gated channel subfamily KQT member 3 3 shared papers
- Sodium channel regulatory subunit beta-2 2 shared papers
- Kinesin-like protein KIF3C 1 shared papers
- Mu-conotoxin KIIIB 1 shared papers
- Sodium channel protein type 2 subunit alpha 3 shared papers
- Syntaxin-binding protein 1 5 shared papers
Literature · 69 cited papers
- Pain-causing stinging nettle toxins target TMEM233 to modulate NaV1.7 function. Nat. Commun. · 2023
- Molecular basis for pore blockade of human Na+ channel Nav1.2 by the mu-conotoxin KIIIA. Science · 2019
- Ketogenic diet as a successful early treatment modality for SCN2A mutation. Brain Dev. · 2019
- Dominant SCN2A Mutation Causes Familial Episodic Ataxia and Impairment of Speech Development. Neuropediatrics · 2018
- Relationship of electrophysiological dysfunction and clinical severity in SCN2A-related epilepsies. Hum. Mutat. · 2018
- Nonsyndromic intellectual disability with novel heterozygous SCN2A mutation and epilepsy. Hum. Genome Var. · 2018
- Dynamic action potential clamp predicts functional separation in mild familial and severe de novo forms of SCN2A epilepsy. Proc. Natl. Acad. Sci. U.S.A. · 2018
- The finding of a new heterozygous mutation site of the SCN2A gene in a monozygotic twin family carrying and exhibiting genetic epilepsy with febrile seizures plus (GEFS+) using targeted next-generation sequencing. Clin. Neurol. Neurosurg. · 2018
- SCN2A mutation in an infant presenting with migrating focal seizures and infantile spasm responsive to a ketogenic diet. Brain Dev. · 2018
- The therapeutic implication of a novel SCN2A mutation associated early-onset epileptic encephalopathy with Rett-like features. Brain Dev. · 2017
- The tarantula toxin beta/delta-TRTX-Pre1a highlights the importance of the S1-S2 voltage-sensor region for sodium channel subtype selectivity. Sci. Rep. · 2017
- Opposing Effects on NaV1.2 Function Underlie Differences Between SCN2A Variants Observed in Individuals With Autism Spectrum Disorder or Infantile Seizures. Biol. Psychiatry · 2017
- … and 57 more in the literature graph
A document in the lmmol reference corpus — open public data (UniProt, GO, PDB, the literature graph) rendered as a single cross-linked page. Hover any link to preview its target.